In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Rifat Ara IslamDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Md Rahatullah RazanDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.ORCID 0000-0002-6999-5224 Ankita PoojariDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.ORCID 0000-0002-2547-5403 Mohammad Moshiur RahmanDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Hao WeiDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Hana S AlhamadshehDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Melanie FelmleeDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.
Atefeh RabieeDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.ORCID 0000-0003-4060-7328 Mitra EsfandiareiBiomedical Sciences Program, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USA.ORCID 0000-0003-3218-7781 Roshanak RahimianDepartment of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.ORCID 0000-0001-9803-0619 Funding
University of the Pacific Jie Du Center for Innovation & Excellence for Drug Discovery
6 · The paper itselfAbstract
Exogenous estrogen use in male-to-female individuals has been linked to increased cardiovascular disease risk, though the mechanisms remain unclear. This study examines the effects of 17β-estradiol (E
Indexed as
AortaEstradiolVasodilationAdipose Tissue, WhiteAnimalsBody WeightEndothelium, VascularGlucose Transporter Type 4InsulinMaleNitric Oxide Synthase Type IIOrchiectomyProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySignal TransductionEstradiolGlucose Transporter Type 4InsulinNitric Oxide Synthase Type IIProto-Oncogene Proteins c-aktaortic relaxationCardiovascular diseaseestrogen-treatmentmale-to-femalenitric oxide (NO)
Identifiers
PMID41009452
PMCPMC12469970
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390